Opioid Diversion, Postal Carrier Dangers Among Industry Concerns With Mail-Back Envelope Requirement

 
• By Derrick Gingery

Brand and generic drug sponsors also tell the US FDA that there are environmental considerations for providing a pre-paid mail-back envelope so patients can send unused opioids for disposal.

Pills in envelope
Industry trade groups raised several concerns about an FDA proposal to require pre-paid mail-back disposal envelopes with all opioid prescriptions. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet